ProfileGDS4718 / 201769_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 97% 97% 97% 98% 97% 98% 98% 98% 98% 98% 98% 98% 96% 98% 99% 98% 97% 98% 96% 98% 98% 98% 98% 99% 98% 98% 97% 98% 98% 98% 96% 99% 98% 98% 98% 99% 98% 98% 97% 98% 97% 96% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.645998
GSM549102patient 115, normal, homogenized [OPG study]11.11497
GSM549104patient 119, normal, homogenized [OPG study]11.059997
GSM549108patient 138, normal, homogenized [OPG study]11.150697
GSM549119patient 077, normal, homogenized [OPG study]11.556798
GSM549133patient 032, cancer, homogenized [OPG study]10.843497
GSM549139patient 042, cancer, homogenized [OPG study]11.330798
GSM549099patient 107, normal, homogenized [OPG study]11.701698
GSM549109patient 139, normal, homogenized [OPG study]11.50998
GSM549110patient 046, normal, homogenized [OPG study]11.8698
GSM549114patient 063, normal, homogenized [OPG study]11.701198
GSM549122patient 082, normal, homogenized [OPG study]11.57598
GSM549134patient 033, cancer, homogenized [OPG study]11.761198
GSM549136patient 036, cancer, homogenized [OPG study]10.511596
GSM549140patient 044, cancer, homogenized [OPG study]11.265398
GSM549111patient 047, normal, homogenized [OPG study]12.205799
GSM549113patient 057, normal, homogenized [OPG study]11.963598
GSM549132patient 031, cancer, homogenized [OPG study]10.63397
GSM549137patient 038, cancer, homogenized [OPG study]11.218298
GSM549142patient 047, cancer, homogenized [OPG study]9.9543296
GSM549100patient 110, normal, homogenized [OPG study]11.242198
GSM549107patient 135, normal, homogenized [OPG study]11.361598
GSM549115patient 068, normal, homogenized [OPG study]12.023298
GSM549116patient 072, normal, homogenized [OPG study]11.629598
GSM549120patient 078, normal, homogenized [OPG study]11.986399
GSM549131patient 030, cancer, homogenized [OPG study]11.252498
GSM549118patient 074, normal, homogenized [OPG study]11.606598
GSM549129patient 027, cancer, homogenized [OPG study]10.439897
GSM549123patient 088, normal, homogenized [OPG study]11.626898
GSM549124patient 006, cancer, homogenized [OPG study]11.074598
GSM549126patient 015, cancer, homogenized [OPG study]11.316998
GSM549128patient 025, cancer, homogenized [OPG study]10.589596
GSM549103patient 117, normal, homogenized [OPG study]11.862699
GSM549117patient 073, normal, homogenized [OPG study]11.760398
GSM549138patient 041, cancer, homogenized [OPG study]11.456198
GSM549141patient 045, cancer, homogenized [OPG study]11.37398
GSM549130patient 028, cancer, homogenized [OPG study]11.825599
GSM549101patient 111, normal, homogenized [OPG study]11.439898
GSM549105patient 128, normal, homogenized [OPG study]11.39698
GSM549106patient 134, normal, homogenized [OPG study]11.098297
GSM549112patient 048, normal, homogenized [OPG study]11.415798
GSM549125patient 011, cancer, homogenized [OPG study]11.038497
GSM549127patient 024, cancer, homogenized [OPG study]10.488496
GSM549135patient 035, cancer, homogenized [OPG study]10.921797